DOI QR코드

DOI QR Code

A Review: Synthesis and characterization of metals complexes with paracetamol drug

  • AL-Ayash, Salam R (Chemistry Department, College of Education for Pure Science Ibn-Al-Haithem, University of Baghdad) ;
  • AL-Noor, Taghreed H (Chemistry Department, College of Education for Pure Science Ibn-Al-Haithem, University of Baghdad)
  • 투고 : 2022.04.07
  • 심사 : 2022.05.24
  • 발행 : 2022.08.25

초록

In this review, previous studies on the synthesis and characterization of the metal Complexes with paracetamol by elemental analysis, thermal analysis, (IR, NMR and UV-Vis (spectroscopy and conductivity. In reviewing these studies, the authors found that paracetamol can be coordinated through the pair of electrons on the hydroxyl O-atom, carbonyl O-atom, and N-atom of the amide group. If the paracetamol was a monodentate ligand, it will be coordinated by one of the following atoms O-hydroxyl, O-carbonyl or N-amide. But if the paracetamol was bidentate, it is coordinated by atoms (O-carbonyl and N-amide), (O-hydroxyl and N-amide) or (O-carbonyl and O-hydroxyl). The authors also found that free paracetamol and its complexes have antimicrobial activity.

키워드

1. Introduction

Paracetamol (N-acetyl-p-aminophenol, acetaminophen, 4-acetamide phenol, or 4-hydroxyacetanilide) (PAPA) is acylated aromatic amide, initially proposed to medicine, which is an analgesic and antipyretic drug adopted to mitigate mild to moderate toxicity pain associated with headache, back pain, arthritis, postoperative pain and fever of bacterial/viral beginning to reduce. PAPA results in serious side effects when over dosed and taken with alcohol or other medications, can cause skin rashes, liver toxicity, kidney damage, liver failure, nephrotoxicity, inflammation of the pancreas and ultimately death1-5. In the United States of America, PAPA overdose accounts for approximately (56,000) emergency room visits, (26,000) hospitalizations, and nearly (500) deaths each year.6

Fig. 1 Structure PAPA, one of the very common and extensively utilized drugs in the world, has a phenolic structure with a substituent in the PAPA position relative to the hydroxyl group, allowing it to react with reactive species.5-7

Fig. 1. Structure PAPA.

Previous studies showed that some metal(II) complexes of PAPA were active against certain types of microorganisms such as [Bacillus-cereus, Pseudomonas -aeruginosa, Klebsiella-oxytoca and Escherichia-coli].8,9 These complexes also have a different effect against bacteria.10

For antioxidants, increasing the intake of PAPA can perform to oxidative stress and kidney damage and cause liver damage.11,12 But ACPH possesses remarkable antioxidant properties when used in therapeutic doses, with cell-free test systems showing that PAPA at a concentration of (210) µM is able to scavenge reactive oxygen directly.13 Although not well understood, PAPA cardioprotective effects appear to be related to its antioxidant properties.14-21

2. Previous studies on the synthesis and characterization of metal ions complexes with paracetamol

El-Shahawy et al. have been synthesized Fe2+, Cu2+ and Zn2+ complexes of Paracetamol, and characterized by elemental analysis (Atomic absorption NMR and FT-IR) spectra. From the above spectral measurements, it was found that the complexes formed through oxygen-(C=O) atom and nitrogen-N atom see in Fig. 2.22

Fig. 2. The structure of (PAPA)2–M(II).

Lawal and Obaleye synthesized and characterized Fe3+ Co2+ and Ni2+ complexes with PAPA using infrared, electronic, and 1H-NMR spectra, conductivity measurements, and melting point. Considering all the above analytical and spectroscopic data, PAPA was observed to act as a bidentate-ligand agent coordinated with metal ions via the O-hydroxyl and the Ocarbonyl.23 The tentatively proposed structures for the chelating agents are shown in Fig. 3.

Fig. 3. Proposed structure for M(PAPA)2Xn.

M = Co2+, Ni2+, n = 2, X = Cl

M = Fe3+, n = 3, X = Cl

Ledeti et al. have synthesized and characterized a coordination compound of Zn(II) with PAPA. The chelate was characterized by elemental analysis, TGDTG-HF technique and FTIR-UATR spectroscopy. The data obtained proved that PAPA acts as a bidentate ligand via the OH-group and the C=O group.

According to the spectroscopic data and the results of the elemental analysis, and to confirm the thermal behavior of the complex, a proposed structure for the metal chelate is shown in Fig. 4.24

Fig. 4. The proposed structure of [Zn(ACPH)2(H2O)2] 2Cl complex

Chandrathilaka, et al. The study binary chelates of Cu2+, Pb2+, Cd2+ and Al3+ were performed with ascorbic acid-(Asc) and PAPA. The stable mixed ligands have been found to chelate; [Cd(PAPA)(Asc)], [Cu(PAPA) (Asc)], and [Pb(PAPA)(Asc)] but Al(III) did not form a chelate that same previous form, it form chelate only with PAPA due to its high stability.25,26 The following structures can be proposed for the obtained chelating agents Fig. 5.27

Fig. 5. Structure of Al(PAPA)2 and [M(PAPA)(Asc)] (M = Pb2+, Cd2+, Cu2+).

Osowole et al. have synthesized chelates of Mn2+, Co2+, Ni2+, Cu2+ and Zn2+ with PAPA and vanillin, and analyzed them by percent metal analysis, magnetic moments, infrared and electronic spectroscopy, melting points, conductivity measurements. From IR spectral data, it was found that the coordination was through the carbonyl oxygen atom of PAPA with metal ions and the structure of all complexes was octahedral geometry Fig. 6.8

Fig. 6. The structures for Metal(II) complexes.

M : Mn2+, Co2+, Ni2+, and Zn2+ X: Cl, NO3, CH3CO2

Agbaje et al. studied synthesise chelates of Mn2+, Fe2+, Co2+, Ni2+, Cu2+ and Zn2+ with sulfamethoxazole- (Sul) and PAPA and were characterized by melting points, magnetic moments, conductivity measurements, metal percent, electronic and infrared spectroscopy. Infrared spectral data confirmed that coordination occurred via OH and C=O oxygen atoms of PAPA. The complex formula [Cu(Sul)(PAPA)(NO3)]2.H2O has a moment of 0.85 BM, suggesting that antiferromagnetism acts through a copper–copper bond in a dimeric structure28,29 (Fig. 7).

Fig. 7. Structure chelate of Cu(II) with PAPA and sulfamethoxazole.

El-Megharbel et al. have synthesized Cd2+, Hg2+, and Pb2+ complexes of the anti-inflammatory drug PAPA. were synthesis and characterized by C.H.N, conductivity, FTIR, 1H-NMR, and UV studies. The oxygen-OH atom is involved in the complexation. These results agree with the results of spectra studies see Fig. 8.30

Fig. 8. The structure of chelate [M(H2O)2(PAPA)2].nH2O. M(II) = Cd, Hg and Pb

Osowole et al. studied M(II) = Mn, Fe, Ni, Cu and Zn mixed ligand chelates of PAPA and benzoic acid were synthesized and characterized by melting points, magnetic moments, infrared, and electronic spectroscopy. Molar conductivity measurements in DMSO indicated that metal(II) chelates were covalent. Infrared spectral data confirmed that coordination occurred via carbonyl-O and hydroxyl-O atoms of PAPA.31 The complexes of the Mn(II) and Cu(II) formula are dimeric (Fig. 9), with the Cl atoms bridging the metal centers and each metal center enhancing the overall magnetic susceptibility of the chelate.32

Fig. 9. Propose structures for the Mn2+ and Cu2+ chelaties.

Adadey, et al. have made Cu-PAPA chelate. By comparing the IR absorption peaks of the metal coordination complexes with PAPA, it turns out that copper coordinated with PAPA via O-acetyl and Namide (Fig. 10).33 Copper could chelate with the PAPA on the CH3 group. This could change the absorption of the CH3 group in the complex (Fig. 11). This implies that the copper forms a chelate with all functional groups and even the benzene ring.23

Fig. 10. The possible constituents of (Cu-PAPA).

Fig. 11. The (Cu) was able to coordinate with (PAPA) via CH3-group.

Babamale et al. studied mixed metal chelate of PAPA and ascorbic acid-Asc synthesized using ZnSO4, CuCl2.2H2O, CoCl2.6H2O, NiCl2.6H2O and FeCl2. 4H2O salts. The chelates were characterized using some physical techniques such as conductivity measurement, melting point, solubility, atomic absorption, UV-Vis and IR spectroscopy. The physical and spectroscopic results show that M is coordinated via the phenol-O and carbonyl-O in PAPA.34 Through all the spectroscopic and analytical data, the structures for the chelating agents are shown in Figs. 12 and 13.

Fig. 12. The structure of PAPA-Asc chelates.

M = Zn(II), Cu(II), Co(II), Ni(II) and Fe(II)

Fig. 13. The structure of PAPA-Asc complex.

M = Cu…… X = Cl2, M = Zn ……X = SO4

Ayipo et al. were obtained from Zn(II), Cu(II), Ni(II), Co(II) and Fe(II) of mixed piperaquine(PQ)- acetylsalicylic acid(AS) and piperaquine(PQ)-PAPA chelates. The chelates were characterized by conductivity measurement, melting point determination, atomic absorption spectroscopy, UV-Vis spectrophoto metry, IR spectroscopy, and magnetic susceptibility. It has been suggested that the chelating agents have a 1:1:1 stoichiometric ratio between each metal salt and the PQ-AS or PQ-PAPA of tetrahedral and octahedral geometry. It was found in this study that the complexes of metal ions form with PAPA via (Nand O-phenol) or (N- and O-carbonyl). both octahedral and tetrahedral chelates. See Figs. 14 and 15.35

Fig. 14. M-(PQ)( PAPA): Where M(II) = Zn, Cu, Ni, Co and Fe.

Y = Cl2, (CH3COO)2, or SO4

Fig. 15. M-(PQ)( PAPA): Where M(II) = Zn, Cu, Ni, Co, and Fe.

Y = Cl2, SO4 or (CH3COO)2

Refat et al. The investigated chelating agents of the divalent metal ions [Sr, Ba, Ca and Mg] with PAPA were synthesized and characterized by IR and 1H-NMR spectroscopy, conductivity, UV-Vis, elemental analysis and thermal analysis. It was revealed by the IR spectral data that the PAPA behaves as a neutral bidentate ligand coordinated to the metal ions through N and O-(C=O) atoms.36 As a general conclusion, the examined chelate structures can be given as shown in Fig. 16.37

Fig. 16. Structure of (PAPA)-complex. M = Sr(II), Ba(II), Ca(II), and Mg(II)

Majthoub et al. have synthesized a zirconium(IV) complex of PAPA in the form of [Zr(PAPA)4(H2O)2] by elemental analysis, UV-Vis, 1H-NMR, and FT-IR spectra. The FT-IR and 1H-NMR spectra explain that PAPA behaves as a monodentate ligand coordinated to the zirconium(IV) ion via the O-phenol atom of the phenol group Fig. 17.38

Fig. 17. Structure of [Zr (PAPA)4(H2O)2].

Faruna et al. have synthesized and characterized Zn(II) and Cu(II) using PAPA X-ray diffraction analysis, (UV-Vis, FTIR) spectroscopy, conductivity and melting point measurements. Based on this study, it is established that PAPA acts as a bidentate ligand coordinated to M2+ through O-(O-H) and O- (C=O) atoms (Fig. 18).9

Fig. 18. The structure of M2+ complexes.

M= Cu(II) and Zn(II)

Olagboye et al. studied Co2+ and Cu2+ mixed ligand chelates of prednisolone and PAPA were synthesized and characterized based on their physical properties melting points and spectroscopic studies. FTIR results in this study showed that the metals possibly coordinated with PAPA via the O-hydroxy group.10

Subhi et al. studied synthesized complexes from PAPA-saccharin (Sac) containing chelating agents with Zn, Cu, Ni, Co, and Mn. These chelating agents are characterized by C.H.N, UV-Vis, molar conductivity, magnetic susceptibility, IR and 1H-NMR. through these measurements, chelating agents are found to be of the type [M(Sac)2(PAPA)2(H2O)2]; where M is any of the above mentioned elements. In addition, the results of spectroscopic measurements show that the PAPA acts as a monodentate ligand of O-carbonyl Fig. 19.39

Fig. 19. The structure [M(Sac)2(PAPA)2(H2O)2] complexes.

M=Ni, Co, Mn, Cu, and Zn

Bhagat has synthesized mixed ligand Cu2+ chelates of the type [Cu(PAPA)(L)].2H2O performed using PAPA and amino acids-(HL) such as L-Valine(Val), L-Threonine(Thr), and L-Serine(Ser). The metal chelates thus synthesized were characterized by elemental analysis, electrical conductivity and spectral analysis UV-Vis and IR. The results of the IR spectroscopic measurements showed that the PAPA acts as a bidentate ligand through O-carbonyl and Ohydroxyl Fig. 20.40

Fig. 20. The structures for the [Cu(PAPA)(L)].2H2O complexes.

Ikpeazu et al. studied the Zn2+ complex with PAPA. The data confirmed that Zn2+ and PAPA combine in a 1:1 molar ratio and the free energy and stability constant results indicated that PAPA is good ligand coordination through the O-hydroxyl and O-carbonyl and an active antidote in the treatment of zinc(II) overload or intoxication.41

Sultan et al. studied the chelate of Al(III) with PAPA, was synthesized and characterized by IR spectroscopy, UV-Vis and melting point. In this study, the PAPA was found to behave as a tridentate chelating agent by being coordinated through the carboxylate Oatom, the phenol O-atom, and the N-atom. Fig. 21.42

Fig. 21. The structure of Al(III) with PAPA complex.

Obaleye et al. studied chelation through synthesis of complexes of metal ions Co2+, Cu2+, Ni2+ and Zn2+ with PAPA and diclofenac potassium salt-(Kdc). The chelates were characterized by conductivity, solubility, elemental analysis, UV-Vis, melting point, FT-IR spectroscopy, X-ray and magnetic susceptibility measurements. The IR spectra showed a bidentate coordination mode. In the case of PAPA, the N- and O-carbonyl atoms were involved.43

Aziz et al. studied complexes of methyldopa-(Meth) with PAPA synthesized using a basic medium to deprotonate the ligands. These complexe of Mn(II), Fe(II), Co(II), Ni(II) and Cu(II) were characterized using (FTIR, UV-visible) spectra, atomic absorption, magnetic susceptibility, (carbon, hydrogen, nitrogen and sulfur)-(CHNS) analysis and melting point measurements. The PAPA was coordinated via the O-atom of the carboxyl group and the N-atom of the amide group.44

Since the PAPA is a bidentate ligand, it forms two bonds with a central atom, so water forms a complexes with these M2+ ions, and due to its monodentate nature Fig. 22.45

Fig. 22. The structure of [M(PAPA)(Meth)(H2O)2] complexes.

M=Mn2+, Fe2+, Co2+, Ni2+ and Cu2+

Hank et al. performed a theoretical study on the synthesis and characterization of copper(II) complexes with PAPA and compared it with the experimental results. The PAPA behaves as a monodentate coordinated ligand for the metal ions through the phenolO. See Fig. 23.46

Fig. 23. The structure of Cu-PAPA complex.

3. Conclusions

Through our review of previous studies on the coordination of paracetamol with some metals. We concluded that paracetamol can be coordinated through the pair of electrons on the hydroxyl O-atom, carbonyl O-atom, or N-atom of the amide group and it can be a monodentate ligand, a bidentate ligand or a tridentate ligand.

참고문헌

  1. E. R. Blough and M. Wu, Frontiers in Pharmacology, 2, Article 72 (2011).
  2. A. Mao, H. Li, D. Jin, L. Yu and X. Hu, Talanta, 144, 252-257 (2015). https://doi.org/10.1016/j.talanta.2015.06.020
  3. S. P. Kumar, K. Giribabu, R. Manigandan, S. Munusamy, S. Muthamizh, A. Padmanaban, T. Dhanasekaran, R. Suresh and V. Narayanan, Electrochimica Acta, 194, 116- 126 (2016). https://doi.org/10.1016/j.electacta.2016.02.087
  4. K. Bharathi, S. P. Kumar, P. S. Prasad and V. Narayanan, Materials Today: Proceedings, 5(2), 8961-8967 (2018). https://doi.org/10.1016/j.matpr.2017.12.336
  5. M. E. Benssassi, L. Mammeri, K. Talbi, B. Lekikot, T. Sehili, J. A. Santaballa and M. Canle, Separation and Purification Technology, 261, 118195 (2021). https://doi.org/10.1016/j.seppur.2020.118195
  6. P. Nourjah, S. R. Ahmad, C. Karwoski and M. Willy, Pharmacoepidemiology and Drug Safety, 15(6), 398- 405 (2006). https://doi.org/10.1002/pds.1191
  7. H. G. Shertzer, S. N. Schneider, E. L. Kendig, D. J. Clegg, D. A. D'Alessio and M. B. Genter, Biochemical Pharmacology, 75(6), 1402-1410 (2008). https://doi.org/10.1016/j.bcp.2007.12.003
  8. A. A. Osowole, O. B. A. Agbaje and B. O. Ojo, Asian Journal of Pharmaceutical and Clinical Research, 7(3), 145-149 (2014).
  9. J. A. Faruna, E. D. Paul and Y. A. Dallatu, International Journal of Biomedical Materials Research, 5(6), 78-83 (2017). https://doi.org/10.11648/j.ijbmr.20170506.13
  10. S. A. Olagboye, D. K. Adekeye and O. A. Akinwunmi, International Journal of Scientific & Engineering Research, 10(3), 651-662 (2019).
  11. J. Ghosh, J. Das, P. Manna and P. C. Sil, Toxicology, 268(1-2), 8-18 (2010). https://doi.org/10.1016/j.tox.2009.11.011
  12. R. Agarwal, L. A. Macmillan-crow, T. M. Rafferty, H. Saba, D. W. Roberts, E. K. Fifer, L. P. James and J. A. Hinson, Journal of Pharmacology and Experimental Therapeutics, 337(1), 110-118 (2011). https://doi.org/10.1124/jpet.110.176321
  13. T.-G. Nam, S. J. Nara, I. Zagol-Ikapitte, T. Cooper, L. Valgimigli, J. A. Oates, N. A. Porter, O. Boutaud and D. A. Pratt, Organic and Biomolecular Chemistry, 7(24), 5103-5112 (2009). https://doi.org/10.1039/b912528k
  14. G. Merrill, P. Mcconnell, K. Vandyke and S. Powell, American Journal of Physiology-Heart and Circulatory Physiology, 280, H2631-H2638, (2001). https://doi.org/10.1152/ajpheart.2001.280.6.h2631
  15. G. F. Merrill and E. Goldberg, Basic Research in Cardiology, 96(5), 423-430 (2001). https://doi.org/10.1007/s003950170023
  16. G. F. Merrill, American Journal of Physiology-Heart and Circulatory Physiology, 282(4), H1341-H1349 (2002). https://doi.org/10.1152/ajpheart.00716.2001
  17. T. H. Rork, N. M. Hadzimichalis, M. A. Kappil and G. F. Merrill, Journal of Molecular and Cellular Cardiology, 40(4), 553-561 (2006). https://doi.org/10.1016/j.yjmcc.2006.01.010
  18. N. M. Hadzimichalis, S. S. Baliga, R. Golfetti, K. M. Jaques, B. L. Firestein and G. F. Merrill, American Journal of Physiology-Heart and Circulatory Physiology, 293(6), H3348-H3355 (2007). https://doi.org/10.1152/ajpheart.00947.2007
  19. E. M. Walker, C. P. Epling, C. Parris, S. Cansino, P. Ghosh, D. H. Desai, E. R. Blough, R. G. Morrison, G. L. Wright, P. Wehner, E. I. Mangiarua and S. M. Walker, Annals of Clinical and Laboratory Science, 37(1), 22-33 (2007).
  20. E. M. Walker, R. G. Morrison, L. Dornon, J. P. Laurino, S. M. Walker, M. Studeny, P. S. Wehner, K. M. Rice, M. Wu and E. R. Blough, Annals of Clinical and Laboratory Science, 39(4), 378-385 (2009).
  21. S. K. Kakarla, J. C. Fannin, S. Keshavarzian, A. Katta, S. Paturi, S. K. Nalabotu, M. Wu, K. M. Rice, K. Manzoor, E. M. Walker and E. R. Blough, Basic Research in Cardiology, 105(4), 535-544 (2010). https://doi.org/10.1007/s00395-010-0094-3
  22. A. S. El-Shahawy, S. M. Ahmed and N. K. Sayed, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 66(1), 143-152 (2007). https://doi.org/10.1016/j.saa.2006.02.034
  23. A. Lawal and J. A. Obaleye, Biokemistri, 19(1), 9-15 (2007).
  24. I. Ledeti, G. Simu, G. Vlase, G. Savoiu, T. Vlase, L.-M. Suta, C. Popoiu and A. Fulias, Rev. Chim. (Bucharest), 64, 1127-1130 (2013).
  25. A. M. D. S. Chandrathilaka, O. A. Ileperuma and C. V. Hettiarachchi, Journal of the National Science Foundation of Sri Lanka, 41(4), 337-344 (2013). https://doi.org/10.4038/jnsfsr.v41i4.6253
  26. A. K. Das, Transition Metal Chemistry, 15(5), 399-402 (1990). https://doi.org/10.1007/BF01177470
  27. E. Kleszczewska, Polish Journal of Environmental Studies, 8, 313-318 (1999).
  28. O. B. Agbaje, S. M. Wakil and A. A. Osowole, Journal of Research & Developments in Chemistry, 2014, 1-12 (2014).
  29. K. Singh, Y. Kumar, P. Puri, G. Singh, Bioinorganic Chemistry and Applications, 2012, Article 729708, (2012).
  30. S. M. E-Megharbel, R. Z. Hamza and M. S. Refat, Spectrochimica Acta Part a: Molecular and Biomolecular Spectroscopy, 131, 534-544 (2014). https://doi.org/10.1016/j.saa.2014.04.108
  31. A. A. Osowole, O. B. A. Agbaje and S. S.Wakil, Int. J. Appl. Med. Sci., 1(2), 77-87 (2015).
  32. P. R. Reddy and A. M. Reddy, Journal of Chemical Sciences, 112(6), 593-600 (2000). https://doi.org/10.1007/BF02704366
  33. S. M. Adadey and J. K. Sarfo, African Journal of Pure and Applied Chemistry, 10(5), 56-62 (2016). https://doi.org/10.5897/AJPAC2016.0701
  34. H. F. Babamale, A. Lawal, O. A. Rajee and E. A. Oloyede, Journal of Applied Sciences and Environmental Management, 20(4), 1157-1161 (2016). https://doi.org/10.4314/jasem.v20i4.32
  35. Y. O. Ayipo, J. A. Obaleye and U. M. Badeggi, Journal of The Turkish Chemical Society Section A: Chemistry, 4(1), 313-326 (2017).
  36. M. S. Refat, G. G. Mohamed, M. Y. El-Sayed, H. M. A. Killa and H. Fetooh, Arabian Journal of Chemistry, 10, S2376-S2387 (2017).
  37. A. Trinchero, S. Bonora, A. Tinti and G. Fini, Biopolymers: Original Research on Biomolecules, 74(1-2), 120-124 (2004). https://doi.org/10.1002/bip.20057
  38. A. Majthoub, E. M. Elsewedy, M. Y. El-Sayed, A. M. A. Adam and M. S. Refat, Research Journal of Pharmaceutical, Biological and Chemical Sciences, 8(1), 646- 652 (2017).
  39. D. S. A. M. Subhi, L. I. Khaleel and M. A. Alheety, AIP Conference Proceedings, 2213(1), 020306 (2020).
  40. D. V. Bhagat, International Journal of Grid and Distributed Computing, 13(2), 154-161 (2020).
  41. O. V. Ikpeazu, I. E. Otuokere and K. K. Igwe, Journal of Applied Sciences and Environmental Management, 24(7), 1137-1143 (2020).
  42. M. A. Sultan, A. E. Karim, A. Kandory and A. Al-Metwali, International Journal of Pharmaceutical Quality Assurance, 10(1), 156-159 (2020).
  43. J. A. Obaleye, A. A. Aliyu, A. O. Rajee and K. E. Bello, Bulletin of the Chemical Society of Ethiopia, 35(1), 77- 86 (2021). https://doi.org/10.4314/bcse.v35i1.6
  44. A. A. Aziz, S. A. Raoof, W. M. Hasan and S. M. Saied, Egyptian Journal of Chemistry, 64(5), 2405-2413 (2021).
  45. J. Singh, A. N. Srivastav, N. Singh, and A. Singh, IntechOpen, O. Hamrani, A. Zerrouk, S. Boutamine S. Kellou-Tairi and Z. Hank, Novel Approaches in Drug Designing & Development, 5(4), 555668 (2021).